Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes

被引:722
作者
Yan, YK [1 ]
Melchart, M [1 ]
Habtemariam, A [1 ]
Sadler, PJ [1 ]
机构
[1] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland
基金
英国惠康基金;
关键词
D O I
10.1039/b508531b
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Our work has shown that certain ruthenium(II) arene complexes exhibit promising anticancer activity in vitro and in vivo. The complexes are stable and water-soluble, and their frameworks provide considerable scope for optimising the design, both in terms of their biological activity and for minimising side-effects by variations in the arene and the other coordinated ligands. Initial studies on amino acids and nucleotides suggest that kinetic and thermodynamic control over a wide spectrum of reactions of Ru(II) arene complexes with biomolecules can be achieved. These Ru( II) arene complexes appear to have an altered profile of biological activity in comparison with metal-based anticancer complexes currently in clinical use or on clinical trial.
引用
收藏
页码:4764 / 4776
页数:13
相关论文
共 98 条
[11]   DNA modifications by antitumor platinum and ruthenium compounds: Their recognition and repair [J].
Brabec, V .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 71, 2002, 71 :1-68
[12]  
BURKE GT, 1970, BIOCHEMISTRY-US, V9, P4297
[13]  
Chen GQ, 2003, CANCER RES, V63, P1853
[14]   Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: Novel recognition mechanisms [J].
Chen, HM ;
Parkinson, JA ;
Morris, RE ;
Sadler, PJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (01) :173-186
[15]   Organometallic ruthenium(II) diamine anticancer complexes: Arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts [J].
Chen, HM ;
Parkinson, JA ;
Parsons, S ;
Coxall, RA ;
Gould, RO ;
Sadler, PJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (12) :3064-3082
[16]   Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers [J].
Chen, HM ;
Parkinson, JA ;
Nováková, O ;
Bella, J ;
Wang, FY ;
Dawson, A ;
Gould, R ;
Parsons, S ;
Brabec, V ;
Sadler, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) :14623-14628
[17]  
Clarke M. J., 1980, MET IONS BIOL SYST, V11, P231
[18]   Ruthenium metallopharmaceuticals (vol 232, pg 69, 2002) [J].
Clarke, MJ .
COORDINATION CHEMISTRY REVIEWS, 2003, 236 (1-2) :207-+
[19]   H-1 NMR, EPR, UV-vis, and electrochemical studies of imidazole complexes of Ru(III), crystal structures of cis-[(Im)(2)(NH3)(4)Ru-III]Br-3 and [(1MeIm)(6)Ru-II] Cl-2 center dot 2H(2)O [J].
Clarke, MJ ;
Bailey, VM ;
Doan, PE ;
Hiller, CD ;
LaChanceGalang, KJ ;
Daghlian, H ;
Mandal, S ;
Bastos, CM .
INORGANIC CHEMISTRY, 1996, 35 (17) :4896-4903
[20]   REDUCTION AND SUBSEQUENT BINDING OF RUTHENIUM IONS CATALYZED BY SUBCELLULAR COMPONENTS [J].
CLARKE, MJ ;
BITLER, S ;
RENNERT, D ;
BUCHBINDER, M ;
KELMAN, AD .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1980, 12 (01) :79-87